TITLE

Procarbazine

AUTHOR(S)
Spivack, Samuel D.
PUB. DATE
December 1974
SOURCE
Annals of Internal Medicine;Dec74, Vol. 81 Issue 6, p795
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Deals with the developments in the use of procarbazine since its approval in 1969 for the treatment of Hodgkin's disease. Mechanism of action of the drug; Other clinical uses of the agent; Other diseases in which procarbazine is useful; Potential toxicities of the drug.
ACCESSION #
6970567

 

Related Articles

  • BEACOPP regimen associated with high rate of OS in high-risk Hodgkin's lymphoma.  // Hem/Onc Today;4/25/2011, Vol. 12 Issue 8, p3 

    The article reports on results of a study which showed the effectiveness of high-dose BEACOPP chemotherapy on children and adolescents who have high-risk Hodgkin's lymphoma.

  • Symptom relief with levamisole in stage IV Hodgkin's disease. Phillips, R.H.; Retsas, S.; Newton, K.A. // British Medical Journal;6/4/77, Vol. 1 Issue 6074, p1447 

    Presents a case report on the important immuno-potentiating effects of anthelmintic drug levamisole in stage four Hodgkin's disease. Investigation of in-vitro and in-vivo potentiation of T cell function in patients with the disease; Use of the drug to patients with advancing Hodgkin's disease;...

  • Sequential radiotherapy and chemotherapy in the treatment of Hodgkin's disease. A progress report. Moore, Melvin R.; Bull, Joan M.; Jones, Stephen E.; Rosenberg, Saul A.; Kaplan, Henry S.; Moore, M R; Bull, J M; Jones, S E; Rosenberg, S A; Kaplan, H S // Annals of Internal Medicine;Jul72, Vol. 77 Issue 1, p1 

    Focuses on a study which examined the efficacy of radiation therapy and chemotherapy in treating Hodgkin's disease. Characteristics of patients; Toxicities that occurred during chemotherapy; Survival of patients.

  • Is escalated BEACOPP a standard therapy for advanced Hodgkin's disease? Carde, Patrice; Cavalli, Franco; Diehl, Volker; Franklin, Jeremy // Hematology Journal;2000, Vol. 1 Issue 4, p282 

    Determines the efficacy of BEACOPP as a standard therapy for advanced Hodgkin's disease. Clarification of the meaning of standard therapy; Features and rationale of escalated BEACOPP; Citation of infertility as a possible side effect of BEACOPP; Dose-response relationship.

  • Lenograstim.  // Reactions Weekly;8/11/2012, Issue 1414, p32 

    The article describes the case of a 19-year-old woman who developed acute respiratory distress syndrome (ARDS) and pulmonary oedema after receiving lenograstim for Hodgkin's disease.

  • Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease. Devita, Vincent T.; Serpick, Arthur A.; Carbone, Paul P. // Annals of Internal Medicine;Dec70, Vol. 73 Issue 6, p881 

    Examines a case involving patients with advanced primarily untreated Hodgkin's disease who were treated with a combination of vinscristine sulfate, nitrogen mustard, procarbazine hydrochloride and prednisone. Information on Hodgkin's disease; Clinical features and response of patients to...

  • Treatment of Hodgkin's Disease: With What and By Whom? Durant, John R. // Annals of Internal Medicine;Dec70, Vol. 73 Issue 6, p1033 

    Focuses on developments in the treatment of Hodgkin's disease. Radiation therapy treatment of patients who have localized disease; Widespread application of extended field therapy; Information on the combination chemotherapy.

  • Advanced Lymphosarcoma: Intensive Cyclical combination Chemotherapy with Cyclophosphamide, vincristine, and Prednisone. Bagley Jr., Charles M.; Devita Jr., Vincent T.; Berard, Costan W.; Canellos, George P. // Annals of Internal Medicine;Feb72, Vol. 76 Issue 2, p227 

    Describes several cases of advanced lymphosarcoma treated with intensive cyclical combination chemotherapy with cyclophosphamide, vincristine and prednisone. Objectives of the study; Clinical features and response to therapy; Details of a cycle of CVP combination chemotherapy.

  • Views.  // British Medical Journal;9/13/1980, Vol. 281 Issue 6242, p749 

    Provides updates related to medicine in Great Britain as of September 1980. Treatment rate of Hodgkin's disease with standard chemotherapy; Infertility of men due to the adverse effect of systemic chemotherapy; Usefulness of placenta organ for practicing techniques of microvascular surgery.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics